Sunshine Biopharma, Inc. (SBFM) Earnings History
Net Loss19 years of earnings data (2007–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Sunshine Biopharma, Inc. (SBFM) Earnings Overview
As of June 23, 2026, Sunshine Biopharma, Inc. (SBFM) reported trailing twelve-month net income of -$6M, reflecting +80.3% year-over-year growth. The company earned $-12.31 per diluted share over the past four quarters, with a net profit margin of -16.5%.
Looking at the long-term picture, SBFM's historical earnings data spans multiple years. The company achieved its highest annual net income of $0 in fiscal 2009.
Sunshine Biopharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CRVS (-$44M net income), IMVT (-$506M net income), NUVB (-$146M net income, -325.3% margin), SBFM has comparable earnings metrics. Compare SBFM vs CRVS →
SBFM Earnings vs Peers
Earnings metrics vs comparable public companies
SBFM Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$6M | -16.4% | -$4M | $-14.40 | -16.5% | -12.3% |
| 2024 | -$5M | -13.9% | -$6M | $-73.20 | -14.7% | -16.7% |
| 2023 | -$5M | +83.2% | -$5M | $-3513.60 | -18.7% | -19.9% |
| 2022 | -$27M | -115.0% | -$9M | $-35236.40 | -615.4% | -199.6% |
| 2021 | -$12M | -346.7% | -$2M | $-95200.00 | -5444.4% | -1068.2% |
| 2020 | -$3M | -67.7% | $-576,874 | $-32148.90 | -3898.7% | -807.8% |
| 2019 | -$2M | +23.0% | $-641,636 | $-188669.40 | -7860.9% | -3037.9% |
| 2018 | -$2M | -107.3% | -$1M | $-1420.00 | -482.1% | -260.9% |
| 2017 | -$1M | +70.3% | $-857,190 | $-238.40 | - | - |
| 2016 | -$3M | -111.5% | $-993,108 | $-1646.30 | - | - |
| 2015 | -$2M | +14.5% | $-780,277 | $-999999.00 | -96774.5% | -45683.7% |
| 2014 | -$2M | +22.4% | -$2M | $-5261.70 | - | - |
| 2013 | -$2M | -251.9% | -$2M | $-8271.90 | - | - |
| 2012 | $-707,952 | -27.3% | $-706,680 | $-2756.80 | - | - |
| 2011 | $-556,000 | -3.5% | $-556,000 | $-2283.30 | - | - |
| 2010 | $-537,000 | - | $-537,000 | $-3507.70 | - | - |
| 2009 | $0 | +100.0% | $-15,651 | $0.00 | - | - |
| 2008 | $-31,105 | -137.0% | $-26,079 | $-664.60 | - | - |
| 2007 | $-13,122 | - | $-13,122 | $-280.40 | - | - |
Download Data
Export SBFM earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
19+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SBFM — Frequently Asked Questions
Quick answers to the most common questions about buying SBFM stock.
What is SBFM earnings per share (EPS)?
SBFM trailing twelve-month (TTM) diluted EPS is $-12.31, reflecting +80.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2007 to 2025 is available in the table on this page.
What is Sunshine Biopharma, Inc.'s net income?
Sunshine Biopharma, Inc. (SBFM) trailing twelve-month net income is $-6M as of 2025. Earnings grew +80.3% year-over-year.
Is SBFM profitable?
SBFM is not currently profitable on a TTM basis, reporting a net loss of $-6M. Net margin is -16.5%. Investors should monitor for a return to profitability.
What is SBFM's earnings growth rate?
SBFM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2007 to 2025.
What are SBFM's profit margins?
Sunshine Biopharma, Inc. net profit margin is -16.5%, operating margin is -12.3%, and gross margin is +32.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is -25.7%.
Is SBFM growing earnings?
Yes, SBFM earnings are accelerating — EPS growth of +80.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-6M. Earnings momentum is strengthening.
What was SBFM's best earnings year?
Sunshine Biopharma, Inc.'s highest annual net income on record is $0.00, achieved in fiscal year 2009. Earnings history on this page spans 2007 to 2025 and includes all annual and quarterly figures.
What were SBFM's earnings last quarter?
SBFM's most recent reported quarter was Q1 2026. Net income was $-1M with diluted EPS of $-2.50. For a full breakdown of all quarters, see the quarterly earnings table on this page.